Published 29 August 2020 Last week it was announced that our longtime colleague and LUDC researcher/SUS clinician Martin Ridderstråle has been appointed Senior Vice President of Patient Care in the Novo Nordisk Foundation. This is not only a remarkable achievement by Martin but also goes to show that our environment fosters excellent scientists and outstanding clinicians. Martin is one of the most

https://www.ludc.lu.se/article/senior-vice-president-patient-care-novo-nordisk-foundation - 2025-02-11

Published 25 September 2020 Karl Bacos, assistant researcher at LUDC is the recipient of 2020 years Medeon stipend of 50 000 sek for his innovative work within epigenetics in diabetes.   Medeonstipendiat 2020, Karl Bacos, PhD, docent, Lund University Diabetes Centre, Picture: Sara Liedholm The Medeon stipend is handed out in connection to the acknowledgement of World Diabetes Day in Skåne which ta

https://www.ludc.lu.se/article/karl-bacos-years-recipient-medeon-stipend - 2025-02-11

Published 13 August 2020 In many studies, bariatric surgery has been highlighted as an almost magical method for weight loss and reversing type 2 diabetes. One question that has remained largely unanswered is how the effect of surgery differs from the effects of a strict low-calorie diet. This question has now been examined by researchers at Lund University in Sweden in a study published in the jo

https://www.ludc.lu.se/article/strict-diet-explains-metabolic-effect-gastric-pass-surgery - 2025-02-11

Published 30 September 2020 Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating. Researchers at Lund University in Sweden have now identified biomarkers that can show in advance how the patient wil

https://www.ludc.lu.se/article/metformin-type-2-diabetes-patients-or-not-researchers-now-have-answer - 2025-02-11

Published 9 October 2020 Should patients with separate variants of type 2 diabetes be treated with different types of drugs? Researchers at Lund University in Sweden and Skåne University Hospital will attempt to answer that question in a new study.   Anders Rosengren (Image: Johan Wingborg) Type 2 diabetes is one of the fastest growing diseases in the world. It is estimated that over 300 million p

https://www.ludc.lu.se/article/new-study-personalized-type-2-diabetes-treatment-launched - 2025-02-11

Published 21 December 2020 Our latest study on COVID-19 transmission risk among healthcare professionals, a collaboration between Prof Magnus Rasmussen (Dep. of Infection Medicine) and Associate Professor Yang De Marinis (Dep. of Clinical Sciences).  The study was conducted on ~500 healthcare professionals and staff members from 9 units at the Skåne University Hospital in Malmö and Lund, as well a

https://www.ludc.lu.se/article/study-covid-19-among-healthcare-professionals - 2025-02-11

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 5 July 2021 Researchers at Lund University Diabetes Centre are studying whether different subgroups of diabetes need different treatment. Newborn babies are already being screened for mutations and genetic tests help families with hereditary breast cancer. Genomic-driven precision medicine (GDPM) is an emerging approach fo

https://www.ludc.lu.se/article/precision-medicine-emerging-approach-complex-diseases - 2025-02-11

By bodil [dot] malmstrom [at] med [dot] lu [dot] se (Bodil Malmström) - published 9 June 2021 Data from participants in Sweden has helped researchers understand the complexity of the corona virus. Photo: Istock During the pandemic, the free COVID Symptom Study app has helped researchers understand the complexity and spread of the corona virus better. “The study has exceeded our expectations since

https://www.ludc.lu.se/article/study-tracks-spread-covid-19-sweden - 2025-02-11

Published 18 June 2021 The grants from the Crafoord Foundation will support a wide range of projects in diabetes research. Photo: Kennet Ruona Researchers from Lund University Diabetes Centre (LUDC) receive 5,3 million SEK in grants from the Crafoord Foundation in southern Sweden. This year, 15 researchers from LUDC are awarded grants for a wide range of projects in diabetes research. In total, re

https://www.ludc.lu.se/article/15-researchers-lund-university-diabetes-centre-receive-millions-funding - 2025-02-11

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 12 November 2021 Yang De Marinis has led the study, which is published in Nature Communications. Photo: Johan Bävman Type 2 diabetes is a complex disease that can lead to serious health problems. It is important to find ways to predict the disease to take preventive measures. A large interdisciplinary study led by Lund Uni

https://www.ludc.lu.se/article/blood-biomarker-identified-predicts-type-2-diabetes-several-years-diagnosis - 2025-02-11

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 31 August 2021 Current screening methods require multiple blood samples. New research shows that a fingerstick blood test can be sufficient. Photo: Petra Olsson Diabetes researchers have established methods for screening people with an increased risk of developing type 1 diabetes. Current methods require multiple blood sam

https://www.ludc.lu.se/article/improved-screening-efficiency-type-1-diabetes-simplified-blood-draw - 2025-02-11

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 12 October 2021 Karl Bacos, a researcher in diabetes and epigenetics, receives a generous grant from the Hjelt Diabetes Foundation. Photo: Petra Olsson Three researchers at Lund University Diabetes Centre (LUDC) receive generous grants from the Hjelt Diabetes Foundation in 2021. Ola Hansson, Karl Bacos and Malin Fex have b

https://www.ludc.lu.se/article/hjelt-foundation-grants-mechanistic-studies-type-2-diabetes - 2025-02-11

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 11 November 2021 Charlotte Ling leads a research group in epigenetics and diabetes at Lund University. Emma Nilsson and Jones Ofori are two of the team members. Photo: Kennet Ruona Metformin is often described as the first-line medication for the treatment of type 2 diabetes. However, not all patients respond to the drug.

https://www.ludc.lu.se/article/diabetes-research-collaboration-can-pave-way-innovation - 2025-02-11

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 12 November 2021 The researcher Emily Sonestedt investigates how our food habits can prevent diseases, such as type 2 diabetes. Photo: Petra Olsson Emily Sonestedt investigates how food affects the health and the risk to develop type 2 diabetes. This knowledge is of importance to society when developing food-based dietary

https://www.ludc.lu.se/article/healthy-eating-reduce-risk-type-2-diabetes - 2025-02-11

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 22 November 2021 Researcher Emma Nilsson has analysed microRNA in fat biopsies from identical twins with and without type 2 diabetes. Photo: Kennet Ruona Identical twins share the same DNA, but one twin may suffer from type 2 diabetes while the other twin does not develop the disease. A study led by Lund University in Swed

https://www.ludc.lu.se/article/twin-study-finds-type-2-diabetes-clues-epigenetic-changes - 2025-02-11

Published 3 December 2021 Charlotte Ling has been awarded a distinguished professor grant within medicine and health between 2021 and 2030. Photo: Kennet Ruona Charlotte Ling, a professor of epigenetics and diabetes at Lund University, has been awarded a distinguished professor grant in medicine and health by the Swedish Research Council.  The grant of 50 million SEK over a period of ten years wil

https://www.ludc.lu.se/article/distinguished-professor-grant-researcher-epigenetics-and-diabetes - 2025-02-11

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 14 December 2021 The study participants were served portions of white wheat bread during the two meals. After the meal intervention, blood sugar and insulin levels differed between different groups of participants. Photo: Petra Olsson A lot of research explains which diets may reduce the risk of developing type 2 diabetes.

https://www.ludc.lu.se/article/bread-study-examines-role-genes-breaking-down-food - 2025-02-11

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 11 January 2022 Dina Mansour Aly, one of the main authors behind the study, has carried out several genetical analyses. Photo: Petra Olsson Previous research from Lund University has shown that diabetes can be divided into five groups with different disease progression. A new study published in Nature Genetics demonstrates

https://www.ludc.lu.se/article/new-research-highlights-genetic-differences-between-different-forms-type-2-diabetes - 2025-02-11

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 28 January 2022 The Swedish diabetes summits are organised by the two Swedish strategic research areas within diabetes. Photo: Kennet Ruona The fourth Swedish diabetes summit will be held as an online meeting on the 10th and 11th of February. The meeting brings together diabetes researchers in Sweden for new interactions a

https://www.ludc.lu.se/article/swedish-diabetes-summit-brings-together-diabetes-researchers-new-collaborations - 2025-02-11

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 31 January 2022 Myriam Aouadi, a researcher in immunometabolism at Karolinska Institutet, receives the Leif C. Groop prize for scientific excellence that will benefit patients with type 2 diabetes. Photo: Karolinska Institutet Myriam Aouadi is awarded the Leif C. Groop award for her research on the mechanisms behind the de

https://www.ludc.lu.se/article/myriam-aouadi-receives-leif-c-groop-award-outstanding-diabetes-research - 2025-02-11